Genelux Common Stock Price Prediction

GNLX Stock   3.40  0.18  5.03%   
At this time, the RSI of Genelux Common's share price is approaching 41. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Genelux Common, making its price go up or down.

Momentum 41

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Genelux Common's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Genelux Common, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Genelux Common's stock price prediction:
EPS Estimate Next Quarter
(0.19)
EPS Estimate Current Year
(0.89)
EPS Estimate Next Year
(1.18)
Wall Street Target Price
18.4
EPS Estimate Current Quarter
(0.19)
Using Genelux Common hype-based prediction, you can estimate the value of Genelux Common from the perspective of Genelux Common response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Genelux Common using Genelux Common's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Genelux using crowd psychology based on the activity and movement of Genelux Common's stock price.

Genelux Common Implied Volatility

    
  5.26  
Genelux Common's implied volatility exposes the market's sentiment of Genelux Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Genelux Common's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Genelux Common stock will not fluctuate a lot when Genelux Common's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Genelux Common to buy its stock at a price that has no basis in reality. In that case, they are not buying Genelux because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Genelux Common after-hype prediction price

    
  USD 3.38  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Genelux Common Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.
Intrinsic
Valuation
LowRealHigh
0.267.2114.16
Details
Naive
Forecast
LowNextHigh
0.083.8410.78
Details
5 Analysts
Consensus
LowTargetHigh
16.7418.4020.42
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.23-0.22-0.21
Details

Genelux Common After-Hype Price Prediction Density Analysis

As far as predicting the price of Genelux Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Genelux Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Genelux Common, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Genelux Common Estimiated After-Hype Price Volatility

In the context of predicting Genelux Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Genelux Common's historical news coverage. Genelux Common's after-hype downside and upside margins for the prediction period are 0.17 and 10.33, respectively. We have considered Genelux Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.40
3.38
After-hype Price
10.33
Upside
Genelux Common is relatively risky at this time. Analysis and calculation of next after-hype price of Genelux Common is based on 3 months time horizon.

Genelux Common Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Genelux Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genelux Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Genelux Common, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.83 
6.95
  0.02 
  0.01 
4 Events / Month
14 Events / Month
In about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.40
3.38
0.59 
34,750  
Notes

Genelux Common Hype Timeline

Genelux Common is currently traded for 3.40. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.01. Genelux is expected to decline in value after the next headline, with the price expected to drop to 3.38. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.59%, whereas the daily expected return is currently at 0.83%. The volatility of related hype on Genelux Common is about 40015.15%, with the expected price after the next announcement by competition of 3.41. About 17.0% of the company shares are held by company insiders. The book value of Genelux Common was currently reported as 0.97. The company recorded a loss per share of 0.94. Genelux Common had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 4 days.
Check out Genelux Common Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.

Genelux Common Related Hype Analysis

Having access to credible news sources related to Genelux Common's direct competition is more important than ever and may enhance your ability to predict Genelux Common's future price movements. Getting to know how Genelux Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Genelux Common may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CMRAComera Life Sciences 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
DYAIDyadic International(0.02)6 per month 0.00  0.01  6.96 (8.59) 46.69 
CINGCingulate(0.07)9 per month 0.00 (0.03) 4.82 (4.97) 24.40 
MNPRMonopar Therapeutics 1.01 8 per month 7.58  0.11  14.92 (11.91) 38.32 
TERNTerns Pharmaceuticals(0.05)6 per month 0.00 (0.23) 5.03 (6.98) 20.46 
DAWNDay One Biopharmaceuticals(0.49)9 per month 0.00 (0.16) 4.59 (6.67) 22.86 
ABOSAcumen Pharmaceuticals(0.08)6 per month 0.00 (0.16) 6.57 (5.85) 19.77 
AMLXAmylyx Pharmaceuticals(0.04)10 per month 0.00 (0.07) 7.20 (9.09) 21.45 
MLTXMoonLake Immunotherapeutics(0.15)8 per month 0.00 (0.12) 4.59 (5.09) 13.46 
GLUEMonte Rosa Therapeutics 0.06 8 per month 0.00 (0.09) 7.68 (8.27) 19.92 
NAMSNewAmsterdam Pharma(0.83)11 per month 2.39  0.10  7.07 (4.59) 47.02 
IVAInventiva Sa(0.03)3 per month 3.18  0.09  5.84 (5.73) 23.67 
CGEMCullinan Oncology LLC(0.37)8 per month 0.00 (0.14) 5.13 (6.43) 15.27 
CMPXCompass Therapeutics 0.11 9 per month 5.34  0.13  14.18 (9.49) 44.59 
LRMRLarimar Therapeutics 0.02 10 per month 0.00 (0.22) 5.82 (7.99) 26.36 
IMRXImmuneering Corp(0.01)8 per month 0.00 (0.05) 6.88 (7.94) 28.83 
CNTACentessa Pharmaceuticals PLC 1.05 11 per month 0.00  0.01  6.30 (5.83) 15.09 
CELCCelcuity LLC 0.17 7 per month 0.00 (0.04) 6.28 (7.81) 21.63 
IKNAIkena Oncology 0.05 4 per month 0.00 (0.08) 4.65 (3.73) 16.13 

Genelux Common Additional Predictive Modules

Most predictive techniques to examine Genelux price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genelux using various technical indicators. When you analyze Genelux charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Genelux Common Predictive Indicators

The successful prediction of Genelux Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Genelux Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Genelux Common based on analysis of Genelux Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Genelux Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Genelux Common's related companies.
 2023 2024 2025 (projected)
Interest Debt Per Share0.270.310.29
Revenue Per Share0.0069590.0080030.007603

Story Coverage note for Genelux Common

The number of cover stories for Genelux Common depends on current market conditions and Genelux Common's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Genelux Common is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Genelux Common's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Genelux Common Short Properties

Genelux Common's future price predictability will typically decrease when Genelux Common's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Genelux Common often depends not only on the future outlook of the potential Genelux Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genelux Common's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding24.4 M
Cash And Short Term Investments23.2 M

Additional Tools for Genelux Stock Analysis

When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.